Alector, Inc. Operating Expenses
Alector, Inc. (ALEC) reported Operating Expenses of $27.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Alector, Inc. operating expenses for the quarter ending 2026-06-30 was $27.71M, a 34.04% decline year-over-year.
- Alector, Inc. operating expenses for the quarter ending 2026-03-31 was $25.96M, a 46.32% decline year-over-year.
- Alector, Inc. operating expenses for the quarter ending 2025-12-31 was $45.80M, a 25.51% decline year-over-year.
- Alector, Inc. operating expenses for the quarter ending 2025-09-30 was $40.87M, a 35.92% decline year-over-year.
- Alector, Inc. operating expenses for fiscal 2025 was $177.05M, a 27.90% decline from fiscal 2024.
- Alector, Inc. operating expenses for fiscal 2024 was $245.56M, a 1.31% decline from fiscal 2023.
- Alector, Inc. operating expenses for fiscal 2023 was $248.80M, a 8.34% decline from fiscal 2022.
- Alector, Inc. operating expenses for fiscal 2022 was $271.45M, a 11.05% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.71M 10-Q · filed 2026-08-06 | $53.68M 10-Q · filed 2026-08-06 | $99.48M derived: sum of 3 quarters · filed 2026-08-06 | $140.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $25.96M 10-Q · filed 2026-05-07 | $71.77M derived: sum of 2 quarters · filed 2026-05-07 | $112.64M derived: sum of 3 quarters · filed 2026-05-07 | $154.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $45.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $86.67M derived: sum of 2 quarters · filed 2026-02-25 | $128.68M derived: sum of 3 quarters · filed 2026-08-06 | $177.05M 10-K · filed 2026-02-25 |
| 2025-09-30 | $40.87M 10-Q · filed 2025-11-06 | $82.88M derived: sum of 2 quarters · filed 2026-08-06 | $131.25M 10-Q · filed 2025-11-06 | $192.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $42.01M 10-Q · filed 2026-08-06 | $90.38M 10-Q · filed 2026-08-06 | $151.87M derived: sum of 3 quarters · filed 2026-08-06 | $215.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $48.37M 10-Q · filed 2026-05-07 | $109.86M derived: sum of 2 quarters · filed 2026-05-07 | $173.63M derived: sum of 3 quarters · filed 2026-05-07 | $234.32M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $61.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $125.27M derived: sum of 2 quarters · filed 2026-02-25 | $185.95M derived: sum of 3 quarters · filed 2026-02-25 | $245.56M 10-K · filed 2026-02-25 |
| 2024-09-30 | $63.78M 10-Q · filed 2025-11-06 | $124.47M derived: sum of 2 quarters · filed 2025-11-06 | $184.07M 10-Q · filed 2025-11-06 | $246.71M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $60.69M 10-Q · filed 2025-08-07 | $120.29M 10-Q · filed 2025-08-07 | $182.93M derived: sum of 3 quarters · filed 2025-08-07 | $242.63M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $59.60M 10-Q · filed 2025-05-08 | $122.24M derived: sum of 2 quarters · filed 2025-05-08 | $181.94M derived: sum of 3 quarters · filed 2025-05-08 | $241.74M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $62.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $122.33M derived: sum of 2 quarters · filed 2025-02-26 | $182.14M derived: sum of 3 quarters · filed 2025-02-26 | $248.80M 10-K · filed 2025-02-26 |
| 2023-09-30 | $59.69M 10-Q · filed 2024-11-06 | $119.50M derived: sum of 2 quarters · filed 2024-11-06 | $186.16M 10-Q · filed 2024-11-06 | $256.04M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $59.80M 10-Q · filed 2024-08-07 | $126.47M 10-Q · filed 2024-08-07 | $196.34M derived: sum of 3 quarters · filed 2025-02-26 | $258.94M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $66.66M 10-Q · filed 2024-05-08 | $136.54M derived: sum of 2 quarters · filed 2025-02-26 | $199.14M derived: sum of 3 quarters · filed 2025-02-26 | $269.52M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $69.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $132.48M derived: sum of 2 quarters · filed 2025-02-26 | $202.85M derived: sum of 3 quarters · filed 2025-02-26 | $271.45M 10-K · filed 2025-02-26 |
| 2022-09-30 | $62.60M 10-Q · filed 2023-11-07 | $132.98M derived: sum of 2 quarters · filed 2023-11-07 | $201.57M 10-Q · filed 2023-11-07 | $271.30M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $70.38M 10-Q · filed 2023-08-03 | $138.97M 10-Q · filed 2023-08-03 | $208.70M derived: sum of 3 quarters · filed 2024-02-27 | $264.78M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $68.60M 10-Q · filed 2023-05-04 | $138.32M derived: sum of 2 quarters · filed 2024-02-27 | $194.40M derived: sum of 3 quarters · filed 2024-02-27 | $256.30M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $69.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $125.81M derived: sum of 2 quarters · filed 2024-02-27 | $187.70M derived: sum of 3 quarters · filed 2024-02-27 | $244.44M 10-K · filed 2024-02-27 |
| 2021-09-30 | $56.08M 10-Q · filed 2022-11-08 | $117.98M derived: sum of 2 quarters · filed 2022-11-08 | $174.72M 10-Q · filed 2022-11-08 | $232.33M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $61.89M 10-Q · filed 2022-08-04 | $118.64M 10-Q · filed 2022-08-04 | $176.25M derived: sum of 3 quarters · filed 2023-02-28 | $235.90M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $56.74M 10-Q · filed 2022-05-05 | $114.36M derived: sum of 2 quarters · filed 2023-02-28 | $174.01M derived: sum of 3 quarters · filed 2023-02-28 | $223.77M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $57.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $117.26M derived: sum of 2 quarters · filed 2023-02-28 | $167.02M derived: sum of 3 quarters · filed 2023-02-28 | $216.27M 10-K · filed 2023-02-28 |
| 2020-09-30 | $59.65M 10-Q · filed 2021-11-04 | $109.41M derived: sum of 2 quarters · filed 2021-11-04 | $158.66M 10-Q · filed 2021-11-04 | $197.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $49.76M 10-Q · filed 2021-08-03 | $99.01M 10-Q · filed 2021-08-03 | $137.35M derived: sum of 3 quarters · filed 2022-02-24 | $174.20M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $49.25M 10-Q · filed 2021-05-05 | $87.59M derived: sum of 2 quarters · filed 2022-02-24 | $124.44M derived: sum of 3 quarters · filed 2022-02-24 | $158.51M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $38.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $75.19M derived: sum of 2 quarters · filed 2022-02-24 | $109.26M derived: sum of 3 quarters · filed 2022-02-24 | $135.62M 10-K · filed 2022-02-24 |
| 2019-09-30 | $36.84M 10-Q · filed 2020-11-10 | $70.91M derived: sum of 2 quarters · filed 2020-11-10 | $97.28M 10-Q · filed 2020-11-10 | $125.44M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $34.07M 10-Q · filed 2020-08-11 | $60.44M 10-Q · filed 2020-08-11 | $88.60M derived: sum of 3 quarters · filed 2021-02-25 | $111.92M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $26.37M 10-Q · filed 2020-05-13 | $54.53M derived: sum of 2 quarters · filed 2021-02-25 | $77.85M derived: sum of 3 quarters · filed 2021-02-25 | $97.19M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $28.16M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $51.48M derived: sum of 2 quarters · filed 2021-02-25 | $70.82M derived: sum of 3 quarters · filed 2021-02-25 | $84.97M 10-K · filed 2021-02-25 |
| 2018-09-30 | $23.32M 10-Q · filed 2019-11-12 | $42.66M derived: sum of 2 quarters · filed 2019-11-12 | $56.80M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $19.34M 10-Q · filed 2019-08-12 | $33.48M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $14.14M 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $36.41M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |